Study Stopped
Physician left practice.
Chitogel CSK-4 Gel as Packing in Tympanoplasty Surgery
The Use of Chitosan Succinamide (Chitogel CSK-4) Gel as Packing in Tympanoplasty Surgery
1 other identifier
observational
N/A
1 country
1
Brief Summary
Little innovation in the material used for middle ear packing has occurred over the past decade, despite the fact that animal models have shown increased acute inflammation and increased fibrosis in the long term histologically. Although Chitosan Succinamide has shown improved wound healing and hemostasis in the nasal cavity mucosa, it has yet to be used as a support material, hemostatic agent, and healing agent in the middle ear. This study will utilize Chitosan Succinamide as an alternative to purified gelatin foam as a support material in primary tympanoplasty surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2021
CompletedFirst Submitted
Initial submission to the registry
January 26, 2021
CompletedFirst Posted
Study publicly available on registry
March 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2021
CompletedDecember 19, 2025
January 1, 2022
10 months
January 26, 2021
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
External auditory canal healing
Physician determines exposed bone and inflammatory response
Assess healing of auditory canal starting 1 week up to one year following surgery.
Tympanic membrane healing
Physician determines failed tympanic membrane healing and inflammatory response.
Assess healing of auditory canal starting 1 week up to one year following surgery.
Study Arms (2)
Packing with Gelfoam
Tympanoplasty surgery with fascia graft (either transcanal or post-auricular) will be preformed. The middle ear and external canal will then be packed with Gelfoam.
Packing with Chitosan succinamide
The surgical intervention and tympanoplasty will be performed as normal. The middle ear and external canal will be packed Chitosan succinamide.
Interventions
Chitogel will be tested for suitability as a packing material in tympanoplasty surgery.
Gelfoam is the current packing material for tympanoplasty surgery.
Eligibility Criteria
Patients eligible for primary tympanoplasty surgery.
You may qualify if:
- Healthy adults
- Single tympanic membrane perforation
You may not qualify if:
- Chronic recurrent infection or otorrhea
- Previous ear surgery for the study ear
- Shellfish allergy
- Cerebral Spinal Fluid (CSF) leak concern
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ascension Providence Hospital Novi Campus
Novi, Michigan, 48374, United States
Related Publications (3)
Valentine R, Athanasiadis T, Moratti S, Hanton L, Robinson S, Wormald PJ. The efficacy of a novel chitosan gel on hemostasis and wound healing after endoscopic sinus surgery. Am J Rhinol Allergy. 2010 Jan-Feb;24(1):70-5. doi: 10.2500/ajra.2010.24.3422.
PMID: 20109331BACKGROUNDNgoc Ha T, Valentine R, Moratti S, Robinson S, Hanton L, Wormald PJ. A blinded randomized controlled trial evaluating the efficacy of chitosan gel on ostial stenosis following endoscopic sinus surgery. Int Forum Allergy Rhinol. 2013 Jul;3(7):573-80. doi: 10.1002/alr.21136. Epub 2013 Jan 16.
PMID: 23322408BACKGROUNDDogru S, Haholu A, Gungor A, Kucukodaci Z, Cincik H, Ozdemir T, Sen H. Histologic analysis of the effects of three different support materials within rat middle ear. Otolaryngol Head Neck Surg. 2009 Feb;140(2):177-82. doi: 10.1016/j.otohns.2008.10.023.
PMID: 19201284BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brent Wilkerson, MD
Physician of Record
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2021
First Posted
March 5, 2021
Study Start
January 14, 2021
Primary Completion
November 3, 2021
Study Completion
November 3, 2021
Last Updated
December 19, 2025
Record last verified: 2022-01